home / stock / slp / slp news


SLP News and Press, Simulations Plus Inc. From 10/25/23

Stock Information

Company Name: Simulations Plus Inc.
Stock Symbol: SLP
Market: NASDAQ
Website: simulations-plus.com

Menu

SLP SLP Quote SLP Short SLP News SLP Articles SLP Message Board
Get SLP Alerts

News, Short Squeeze, Breakout and More Instantly...

SLP - Expected US Company Earnings on Wednesday, October 25th, 2023

St. Joe Company (The) (JOE) is expected to report for Q1 2024 Meta Platforms Inc. (META) is expected to report $3.62 for Q3 2023 Industrial Logistics Properties Trust (ILPT) is expected to report $0.11 for Q3 2023 Mid-America Apartment Communities Inc. (MAA) is expected to report $2.2...

SLP - Expected earnings - Simulations Plus Inc.

Simulations Plus Inc. (SLP) is expected to report for Q4 2023

SLP - Simulations Plus Q4 Earnings Preview

2023-10-24 17:35:55 ET More on Simulations Plus Seeking Alpha’s Quant Rating on Simulations Plus Historical earnings data for Simulations Plus Dividend scorecard for Simulations Plus Financial information for Simulations Plus For further detail...

SLP - Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Conference call to be on Wednesday, October 25, 2023, at 5 p.m. EDT Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2023 financial results after the market close on Wednesday, October 25, 2023. ...

SLP - Simulations Plus Receives New FDA Grant Award

Collaboration with regulatory, industry, and academic partners will support and accelerate the development and validation of workflows to conduct virtual bioequivalence studies Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the ph...

SLP - Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors

Immersive activities helped attendees globally learn and apply best practices for PBPK modeling Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, announced the successful completion of...

SLP - Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

Dr. Lukacova’s outstanding contributions to pharmaceutical research and innovation to be recognized with seven others at AAPS PharmSci 360 Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology ...

SLP - Certara downgraded at Jefferies on growth headwinds

2023-08-22 12:07:22 ET Certara ( NASDAQ: CERT ) traded lower on Tuesday after Jefferies downgraded the stock to Hold from Buy, citing a lower likelihood of growth for the health tech company in 2024. The downgrade comes after Certara ( CERT ) CFO John Gallagher painted a neg...

SLP - Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

Elevated ALT levels during clinical trials led researchers to use quantitative systems toxicology (QST) software to better understand potential underlying mechanisms Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharm...

SLP - Simulations Plus Releases ADMET Predictor® 11

New functionality, models, and partner data power predictive accuracy from the industry-leading machine learning platform Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announ...

Previous 10 Next 10